Patient characteristic at time of ovarian cryopreservation and total amount of ovarian cortex evaluated in the study
| Patient no. . | Age at cryopreservation, y . | Type of leukemia . | Total amount of ovarian cortex evaluated, % of 1 ovary . | Disease status at ovarian cryopreservation . |
|---|---|---|---|---|
| 1 | 15 | ALL | 9 | CR |
| 2 | 13 | CML | 18 | Chronic phase |
| 3 | 15 | ALL | 11 | CR |
| 4 | 26 | CML | 20 | Chronic phase |
| 5 | 18 | ALL | 18 | CR |
| 6 | 4 | ALL | 29 | CR |
| 7 | 21 | AML | 15 | CR |
| 8 | 3 | AML | 13 | CR |
| 9 | 23 | ALL | 9 | CR |
| 10 | 4 | ALL | 22 | CR |
| 11 | 21 | AML | 8 | CR |
| 12 | 9 | ALL | 30 | CR |
| 13 | 5 | AML | 15 | CR |
| 14 | 18 | ALL | 7 | Active phase |
| 15 | 17 | CML | 11 | Chronic phase |
| 16 | 15 | AML | 8 | CR |
| 17 | 24 | ALL | 9 | Unknown |
| 18 | 18 | AML | 9 | Active phase |
| 19 | 23 | ALL | 8 | CR |
| 20 | 2 | JMML | 18 | Active phase |
| 21 | 31 | AML | 10 | CR |
| 22 | 3 | AML | 14 | CR |
| 23 | 20 | AML | 7 | * |
| 24 | 11 | ALL | 10 | CR |
| 25 | 20 | AML | 8 | CR |
| Patient no. . | Age at cryopreservation, y . | Type of leukemia . | Total amount of ovarian cortex evaluated, % of 1 ovary . | Disease status at ovarian cryopreservation . |
|---|---|---|---|---|
| 1 | 15 | ALL | 9 | CR |
| 2 | 13 | CML | 18 | Chronic phase |
| 3 | 15 | ALL | 11 | CR |
| 4 | 26 | CML | 20 | Chronic phase |
| 5 | 18 | ALL | 18 | CR |
| 6 | 4 | ALL | 29 | CR |
| 7 | 21 | AML | 15 | CR |
| 8 | 3 | AML | 13 | CR |
| 9 | 23 | ALL | 9 | CR |
| 10 | 4 | ALL | 22 | CR |
| 11 | 21 | AML | 8 | CR |
| 12 | 9 | ALL | 30 | CR |
| 13 | 5 | AML | 15 | CR |
| 14 | 18 | ALL | 7 | Active phase |
| 15 | 17 | CML | 11 | Chronic phase |
| 16 | 15 | AML | 8 | CR |
| 17 | 24 | ALL | 9 | Unknown |
| 18 | 18 | AML | 9 | Active phase |
| 19 | 23 | ALL | 8 | CR |
| 20 | 2 | JMML | 18 | Active phase |
| 21 | 31 | AML | 10 | CR |
| 22 | 3 | AML | 14 | CR |
| 23 | 20 | AML | 7 | * |
| 24 | 11 | ALL | 10 | CR |
| 25 | 20 | AML | 8 | CR |
CR indicates complete remission; ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; CML, chronic myeloid leukemia; and JMML, juvenile myelomonocytic leukemia.
Patient had received a full cycle of intravenous chemotherapy, but was not in complete remission until after the second cycle.